Essential items for lab duties ( immunocap spec. IGE- conjugate)

Ended Awarded Last action

Contract number
HT009026FH024
Awardee
Awarding agency
Obligated
$84,783

Award facts

Contract value 100% obligated
$84,782.70 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 5 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Portage, MI 49002, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Phadia US Inc. on April 20, 2026, for essential immunodiagnostic items with a ceiling value of $84,782.70. The call procures IMMUNOCAP SPEC IGE-conjugate supplies for lab duties. Work is performed in Portage, Michigan, and is scheduled for completion by September 30, 2026. Pricing is firm fixed price under an open market procurement with no set-aside applied.

Quick answers

Who was awarded contract HT009026FH024?

HT009026FH024 was awarded to Phadia US Inc. by Defense Health Agency (Department of Defense) on April 20, 2026.

How much is contract HT009026FH024 worth?

The government has obligated $84,783 on HT009026FH024.

Is contract HT009026FH024 an order under another contract?

Yes. HT009026FH024 is a BPA call under FA301624A0046, a blanket purchase agreement.

Was contract HT009026FH024 competed?

The extent of competition for HT009026FH024 was competed under sap. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award